Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 131 citing Harjai: Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine,.... (0.09 sec) 

Guidelines and recommendations for laboratory analysis in the diagnosis and management …

- clinchem.org
DB Sacks, DE Bruns, DE Goldstein, NK … - Clinical Chemistry, 2002 - Am Assoc Clin Chem
Cited by 556 - Related articles - BL Direct - All 15 versions

Cardiovascular disease and chronic renal disease: a new paradigm


MJ Sarnak, AS Levey - American Journal of Kidney Diseases, 2000 - Elsevier
Cardiovascular disease (CVD) is a major cause of morbidity and mortality among
patients with chronic renal disease (CRD). Despite improvement in treatment for
CVD over the past 30 years, CVD mortality is approximately 15 times higher ...
Cited by 302 - Related articles - BL Direct - All 6 versions

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

- endojournals.org
A Colao, D Ferone, P Marzullo, G Lombardi - Endocrine Reviews, 2004 - Endocrine Soc
This review focuses on the systemic complications of acromegaly. Mortality in
this disease is increased mostly because of cardiovascular and respiratory
diseases, although currently neoplastic complications have been questioned ...
Cited by 263 - Related articles - BL Direct - All 4 versions

Growth hormone and the heart


A Colao, P Marzullo, C Di Somma, G … - Clinical Endocrinology, 2001 - interscience.wiley.com
Impaired cardiovascular function has recently been demonstrated to potentially
reduce life expectancy both in GH deficiency and excess. Experimental and
clinical studies have supported the evidence that GH and IGF-I are ...
Cited by 214 - Related articles - BL Direct - All 7 versions

Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular …


TY Wong, R Klein, BEK Klein, JM Tielsch, L … - Survey of ophthalmology, 2001 - Elsevier
Retinal microvascular abnormalities, such as generalized and focal arteriolar
narrowing, arteriovenous nicking and retinopathy, reflect cumulative vascular
damage from hypertension, aging, and other processes. Epidemiological ...
Cited by 190 - Related articles - BL Direct - All 5 versions

Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke …


PB Gorelick - Stroke, 2002 - Am Heart Assoc
Background— It is estimated that about half of cardiovascular disease risk is
explained by conventional risk factors. The realization that atherosclerosis is
an inflammatory disease has led to a search for new stroke and ...
Cited by 194 - Related articles - BL Direct - All 9 versions

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, …

- endojournals.org
F Orio Jr, S Palomba, L Spinelli, T Cascella, … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
To evaluate the cardiovascular risk of polycystic ovary syndrome (PCOS), we
investigated lipid profile, metabolic pattern, and echocardiography in 30 young
women with PCOS and 30 healthy age- and body mass index (BMI)-matched ...
Cited by 138 - Related articles - BL Direct - All 5 versions

The cardiac-specific nuclear delta B isoform of Ca2+/calmodulin-dependent protein kinase …

- jbc.org
T Zhang, EN Johnson, Y Gu, MR Morissette, … - Journal of Biological Chemistry, 2002 - ASBMB
The isoform of Ca 2+ /calmodulin-dependent protein kinase II (CaMKII)
predominates in the heart. To investigate the role of CaMKII in cardiac
function, we made transgenic (TG) mice that express the nuclear B isoform ...
Cited by 112 - Related articles - BL Direct - All 5 versions

Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart …

- oxfordjournals.org
T Zhang, JH Brown - Cardiovascular research, 2004 - cardiovascres.oxfordjournals.org
Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), a critical transducer of
Ca 2+ signaling, is a multifunctional protein kinase which can phosphorylate a
wide range of substrates and regulate numerous cellular functions. The ...
Cited by 106 - Related articles - All 6 versions

Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic …

- donabee.com [PDF] 
SK Wattanapitayakul, JA Bauer - Pharmacology and Therapeutics, 2001 - Elsevier
Despite some recent declines, cardiovascular disease (CVD) remains the major
cause of death in the United States and worldwide. Most recent advances in the
treatment of CVD states have been produced by inhibition of mechanisms ...
Cited by 79 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google